自动化胰岛素输注系统在儿童和青少年1型糖尿病患者中的应用:门诊随机对照试验的系统综述与Meta分析
该系统综述与Meta分析纳入25项门诊随机对照试验共1345例儿童和青少年1型糖尿病患者,比较自动化胰岛素输注系统与常规胰岛素治疗。自动化胰岛素输注系统使目标范围内时间(TIR)提高11.38%(95%CI 9.01-13.76,P<0.001,高确定性),低于范围时间(TBR)降低0.59%(95%CI -1.02至-0.15,P=0.008,低确定性),高于范围时间(TAR)降低12.19%(95%CI -14.65至-9.73,P<0.001,高确定性)。结论认为自动化胰岛素输注系统在门诊儿童和青少年1型糖尿病患者中比常规胰岛素治疗更有效。
要点
- 自动化胰岛素输注系统使儿童和青少年1型糖尿病患者TIR提高11.38%(95%CI 9.01-13.76,P<0.001,高确定性)。
- 自动化胰岛素输注系统使TBR降低0.59%(95%CI -1.02至-0.15,P=0.008,低确定性)。
- 自动化胰岛素输注系统使TAR降低12.19%(95%CI -14.65至-9.73,P<0.001,高确定性)。
核心结论
- 自动化胰岛素输注系统在门诊儿童和青少年1型糖尿病患者中比常规胰岛素治疗更有效,且短期和长期效果一致。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Embase、Cochrane对照试验中心注册库和ClinicalTrials.gov至2023年5月4日,纳入25项门诊随机对照试验共1345例参与者,比较自动化胰岛素输注系统与常规胰岛素治疗,研究注册于PROSPERO(2023,CRD42023395252)。
主要发现
- 自动化胰岛素输注系统使TIR提高11.38%(95%CI 9.01-13.76,P<0.001,高确定性)。
- 自动化胰岛素输注系统使用3个月时TIR提高10.46%(95%CI 8.71-12.20),6个月时提高10.87%(95%CI 7.11-14.63)。
- 自动化胰岛素输注系统使TBR降低0.59%(95%CI -1.02至-0.15,P=0.008,低确定性)。
- 自动化胰岛素输注系统使TAR降低12.19%(95%CI -14.65至-9.73,P<0.001,高确定性)。
关键数值与推荐
- TIR定义为3.9-10 mmol/L,TBR定义为<3.9 mmol/L,TAR定义为>10 mmol/L。
- 自动化胰岛素输注系统对比常规胰岛素治疗:TIR的MD为11.38%(95%CI 9.01-13.76),TBR的MD为-0.59%(95%CI -1.02至-0.15),TAR的MD为-12.19%(95%CI -14.65至-9.73)。
局限性
- 大多数分析中观察到显著异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The glycemic control of automated insulin delivery (AID) systems in outpatient children and adolescents with type 1 diabetes (T1D) has not been systematically evaluated. PURPOSE: To evaluate the efficacy and safety of AID systems in children and adolescents in outpatient settings. DATA SOURCES: PubMed, Embase, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov were searched until 4 May 2023. This study was registered with PROSPERO (2023, CRD42023395252). STUDY SELECTION: Randomized controlled trials that compared AID systems with conventional insulin therapy in outpatient children and adolescents with T1D and reported continuous glucose monitoring outcomes were selected. DATA EXTRACTION: Percent time in range (TIR) (3.9-10 mmol/L), time below range (TBR) (<3.9 mmol/L), and time above range (TAR) (>10 mmol/L) were extracted. Data were summarized as mean differences (MDs) with 95% CIs. DATA SYNTHESIS: Twenty-five trials (1,345 participants) were included in the meta-analysis. AID systems were associated with an increased percentage of TIR (MD, 11.38% [95% CI 9.01-13.76], P < 0.001; high certainty). The favorable effect was consistent whether AID was used over 3 months (10.46% [8.71-12.20]) or 6 months (10.87% [7.11-14.63]). AID systems had a favorable effect on the proportion of TBR (-0.59% [-1.02 to -0.15], P = 0.008; low certainty) or TAR (-12.19% [-14.65 to -9.73], P < 0.001; high certainty) compared with control treatment. LIMITATIONS: Substantial heterogeneity was observed in most analyses. CONCLUSIONS: AID systems are more effective than conventional insulin therapy for children and adolescents with T1D in outpatient settings. The favorable effect is consistent both in the short term and long term.
引用
- Zeng B, Gao L, Yang Q, et al. Automated Insulin Delivery Systems in Children and Adolescents With Type 1 Diabetes: A Systematic Review and Meta-analysis of Outpatient Randomized Controlled Trials. Diabetes Care. 2023. PMID: 38011519. doi:10.2337/dc23-0504
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。